pyridoxamine has been researched along with Glucose Intolerance in 2 studies
Glucose Intolerance: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Previously, we reported the possible effect of pyridoxamine (K-163), an AGE inhibitor, on improvement of glucose intolerance in type 2 diabetes mellitus KK-A(y)/Ta mice." | 7.75 | Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice. ( Funabiki, K; Gohda, T; Hagiwara, S; Horikoshi, S; Ito, T; Matsumoto, M; Murakoshi, M; Ohara, I; Tanimoto, M; Tomino, Y; Yamazaki, T, 2009) |
| " Previously, we reported the possible effect of pyridoxamine (K-163), an AGE inhibitor, on improvement of glucose intolerance in type 2 diabetes mellitus KK-A(y)/Ta mice." | 3.75 | Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice. ( Funabiki, K; Gohda, T; Hagiwara, S; Horikoshi, S; Ito, T; Matsumoto, M; Murakoshi, M; Ohara, I; Tanimoto, M; Tomino, Y; Yamazaki, T, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiazza, F | 1 |
| Cento, AS | 1 |
| Collotta, D | 1 |
| Nigro, D | 1 |
| Rosa, G | 1 |
| Baratta, F | 1 |
| Bitonto, V | 1 |
| Cutrin, JC | 1 |
| Aragno, M | 1 |
| Mastrocola, R | 1 |
| Collino, M | 1 |
| Hagiwara, S | 1 |
| Gohda, T | 1 |
| Tanimoto, M | 1 |
| Ito, T | 1 |
| Murakoshi, M | 1 |
| Ohara, I | 1 |
| Yamazaki, T | 1 |
| Matsumoto, M | 1 |
| Horikoshi, S | 1 |
| Funabiki, K | 1 |
| Tomino, Y | 1 |
2 other studies available for pyridoxamine and Glucose Intolerance
| Article | Year |
|---|---|
Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction.
Topics: Albumins; Animals; Body Weight; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; | 2017 |
Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adipokines; Adipose Tissue; Animals; Antioxidants; Cholesterol; Deoxygu | 2009 |